Biolitec owns a European patent on an endoluminal laser ablation device which comprises a flexible wave guide (optical fiber) which at the distal end includes a radiation emitting surface to emit radiation laterally with respect to the axis of the fiber. Tobrix commercializes two types of optical fiber for treatment of varicose veins that allegedly infringe the patent. Biolitec claimed infringement and requested inter alia an injunction, while Tobrix counterclaimed for revocation. In response, Biolitec filed several auxiliary requests.

The cited prior art documents were US patent application 2005/0131400 on endovenous closure of varicose veins with infrared laser, and a publication of Heinze et al. on modified fiber tips for light application in hollow organs.

In a parallel procedure in Italy the patent was found invalid, while in Germany the case has been bifurcated.

Case date: 15 April 2020
Case number: C/09/553579 / HA ZA 18-593
Court: District Court of The Hague

A full summary of this case has been published on Kluwer IP Law.


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.


Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF